Innate Pharma(DE:IDDA)
€1.16+-0.02 (+3.57%)
DE:IDDA
Innate Pharma Revenue
€1.16
At close:+-0.02 (+3.57%)
Innate Pharma (IDDA) Revenue
1 Followers
Innate Pharma Revenue
Innate Pharma had a revenue of 5.66M in the quarter ending Jun 30, 2026, with 373.18%. This bring the company's revenue in the last twelve months to 3.59M, Increased 28.81%. In the fiscal year ending Dec 31, 2025, Innate Pharma had annual revenue of 2.79M with -77.92% growth.
- Revenue (ttm)
- 3.59M
- Revenue Growth
- ―
- P/S Ratio
- 52.90
- Revenue/Employee
- EUR 17,098
- Employees
- 163
- Market Cap
- EUR 147.44M
Revenue Chart
Innate Pharma Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.79M | -9.83M | -77.92% |
| Dec 31, 2024 | 12.62M | -39.28M | -75.68% |
| Dec 31, 2023 | 51.90M | -5.77M | -10.01% |
| Dec 31, 2022 | 57.67M | 45.56M | 376.17% |
| Dec 31, 2021 | 12.11M | -57.66M | -82.64% |
| Dec 31, 2020 | 69.77M | 800.00K | 1.16% |
| Dec 31, 2019 | 68.97M | -10.92M | -13.67% |
| Dec 31, 2018 | 79.89M | 47.26M | 144.83% |
| Dec 31, 2017 | 32.63M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.